Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)

NCT03251144 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

HIV/AIDS
Antiviral Toxicity
Antiviral Drug Adverse Reaction
Mitochondrial Alteration

Interventions

DRUG: Switch to E/C/FTC/TAF daily

Sponsor

University of California, Los Angeles

Collaborators

[object Object]